Intranasal alfentanil for severe intractable angina in inoperable coronary artery disease

Abstract

Chronic refractory angina can lead to multiple acute hospital admissions. This can be due to patient and healthcare professional misconceptions regarding the meaning of the chest pain experienced. Symptom control, psychological support and education form an important part of the management of this condition. We describe a case study where intranasal alfentanil provided rapid relief of symptoms preventing repeated hospital admissions.

Keywords

alfentanil administration intranasal angina pectoris pain intractable

Get full access to this article

View all access options for this article.

References

Chester MR Chronic refractory angina: time to sort out a neglected and growing problem . Brit J Cardiol 2000; 7(3): 108-111.

Silfast T. , Saarnivaara L. Comparison of alfentanil and morphine in the prehospital treatment of patients with acute ischaemic-type chest pain. Eur J Emerg Med 2001; 8(4): 275-278.

Streibel HW , Pommerening J. , Reiger A. Intranasal fentanyl titration for postoperative pain management in an unselected population. Anaesthesia 1993; 48: 753-757.

Schwagmeier R. , Boerger N. , Meissner W. , Walter Striebel H. Pharmacokinetices of Intranasal Alfentanil. J Clin Anaesthesia 1995; 7: 109-113.

Chester MR , Bridson JD Alternative treatments for angina. Heart 2007 ; 93: 983-984.

Davies MJ Coronary disease: the pathophysiology of acute coronary syndromes. Heart 2000; 83: 361-366.

Moore RK , Groves D. , Bateson S. , et al. Health related quality of life of patients with refractory angina before and one year after enrolment onto a refractory angina programme. Eur J Pain 2005; 9: 305-310.

Roger KG , Moore RK , Groves DG , et al. A brief cognitive behavioural intervention reduces hospital admissions in refractory angina patients. J Pain Symptom Manage 2007; 33(3): 310-316.